Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05009771

Postoperative Pain Management of Caesarean Section

Sponsor: Mackay Memorial Hospital

View on ClinicalTrials.gov

Summary

Caesarean section is one of the most frequent surgeries causing severe postoperative pain. Poor management of acute pain can contribute to postoperative complications, late recovery and the development of chronic pain. Moreover, it had been demonstrated that the intensity of postpartum pain is associated with depression. It is imperative to find out appropriate methods of postpartum pain alleviation. Currently, a lot of analgesic drugs and methods have been developed and used in clinical practice, such as patient-controlled analgesia, extended-release analgesics and multimodal analgesia. This prospective cohort study is aimed to investigate the outcome of each postoperative analgesic method used in caesarean section.

Official title: Postoperative Pain Management of Caesarean Section: a Prospective, Observational Cohort Study

Key Details

Gender

FEMALE

Age Range

20 Years - 40 Years

Study Type

OBSERVATIONAL

Enrollment

100

Start Date

2022-02-23

Completion Date

2026-07-31

Last Updated

2025-05-09

Healthy Volunteers

No

Interventions

DRUG

Intravenous patient-control analgesia

At the two trial sites, IV-PCA is commonly used with morphine. The device is installed after delivery and removed within 3 days.

DRUG

Dinalbuphine sebacate

Dinalbuphine sebacate is a prodrug of nalbuphine. With oil-based formulation, the active ingredient releases slowly and the effect lasts longer than nalbuphine. After delivery, a single 150 mg dose of dinalbuphine sebacate is administered intramuscularly.

Locations (2)

MacKay Memorial Hospital Tamsui Branch

New Taipei City, Taiwan, Taiwan

MacKay Memorial Hospital

Taipei, Taiwan, Taiwan